Axim Biotechnologies annual gross profit
2014
2015
2016
2017
2018
2019
2020
2023
2024
Axim Biotechnologies Gross Profit Growth & History (AXIM)
Axim Biotechnologies's gross profit was $63,121 for fiscal 2024.
View full Axim Biotechnologies company overviewAxim Biotechnologies annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $63,121 | $23,603 | +59.73% |
| 2023 | 2023-12-31 | $39,518 | — | — |
| 2020 | 2020-12-31 | $0 | $0 | — |
| 2019 | 2019-12-31 | $0 | −$187,103 | — |
| 2018 | 2018-12-31 | $187,103 | $182,387 | +3867.41% |
| 2017 | 2017-12-31 | $4,716 | $111,787 | — |
| 2016 | 2016-12-31 | −$107,071 | −$105,823 | — |
| 2015 | 2015-12-31 | −$1,248 | −$1,248 | — |
| 2014 | 2014-12-31 | $0 | — | — |
Axim Biotechnologies quarterly gross profit
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q3.20
Q1.21
Q2.21
Q3.21
Q3.22
Q2.23
Q2.24
Q1.25
Q2.25
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | $0 | −$15,735 | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q2 2024 | 2024-06-30 | $15,735 | $5,806 | +58.48% |
| Q2 2023 | 2023-06-30 | $9,929 | — | — |
| Q3 2022 | 2022-09-30 | $1,314 | −$6,813 | −83.83% |
| Q3 2021 | 2021-09-30 | $8,127 | $8,127 | — |
| Q2 2021 | 2021-06-30 | $14,875 | — | — |
| Q1 2021 | 2021-03-31 | $32,649 | $32,649 | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $0 | −$12,680 | — |
| Q4 2019 | 2019-12-31 | −$18,127 | −$183,748 | — |
| Q3 2019 | 2019-09-30 | $0 | −$3,049 | — |
| Q2 2019 | 2019-06-30 | $5,447 | −$446 | −7.57% |
| Q1 2019 | 2019-03-31 | $12,680 | $140 | +1.12% |
| Q4 2018 | 2018-12-31 | $165,621 | $150,961 | +1029.75% |
| Q3 2018 | 2018-09-30 | $3,049 | −$5,065 | −62.42% |
| Q2 2018 | 2018-06-30 | $5,893 | $3,641 | +161.68% |
| Q1 2018 | 2018-03-31 | $12,540 | $32,850 | — |
| Q4 2017 | 2017-12-31 | $14,660 | $115,620 | — |
| Q3 2017 | 2017-09-30 | $8,114 | $12,175 | — |
| Q2 2017 | 2017-06-30 | $2,252 | $3,093 | — |
| Q1 2017 | 2017-03-31 | −$20,310 | −$19,101 | — |
| Q4 2016 | 2016-12-31 | −$100,960 | −$98,820 | — |
| Q3 2016 | 2016-09-30 | −$4,061 | $7,159 | — |
| Q2 2016 | 2016-06-30 | −$841 | −$12,953 | — |
| Q1 2016 | 2016-03-31 | −$1,209 | −$1,209 | — |
| Q4 2015 | 2015-12-31 | −$2,140 | — | — |
| Q3 2015 | 2015-09-30 | −$11,220 | −$11,220 | — |
| Q2 2015 | 2015-06-30 | $12,112 | — | — |
| Q1 2015 | 2015-03-31 | $0 | — | — |
| Q3 2014 | 2014-09-30 | $0 | — | — |
Axim Biotechnologies gross profit trends
Over the last five fiscal years, Axim Biotechnologies's gross profit increased from $0 to $63,121, a change of $63,121. The latest reported quarter, Q2 2025, shows $0.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Axim Biotechnologies source filings ↗